Recent Quotes
My Watchlist
Indicators
Local Stocks
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

145.95 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jun 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 494
Open 145.95
Bid (Size) 145.44 (1)
Ask (Size) 146.16 (1)
Prev. Close 145.95
Today's Range 145.95 - 145.95
52wk Range 143.13 - 175.97
Shares Outstanding 2,628,679,824
Dividend Yield 3.26%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Beasley Allen and Levin Papantonio: Leading Law Firms Seek Protection for Future Victims of Johnson & Johnson Talc Products
From Beasley Allen
Via Business Wire
Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst
Legend Biotech analyst predicts growth for Carvykti. The Multiple Myeloma drug could become a $5B+ product. 
Via Benzinga

Performance

YTD
-8.76%
-8.76%
1 Month
-3.52%
-3.52%
3 Month
-6.90%
-6.90%
6 Month
-6.11%
-6.11%
1 Year
-11.08%
-11.08%

More News

Read More
What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday?
Via Benzinga
Market Analysis: Johnson & Johnson And Competitors In Pharmaceuticals Industry
Via Benzinga
In-Depth Examination Of 11 Analyst Recommendations For Johnson & Johnson
Via Benzinga
How Is The Market Feeling About Johnson & Johnson?
Via Benzinga
Uncovering Dividend Opportunities with NYSE:JNJ.
Via Chartmill
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
Via FinancialNewsMedia
The 7 Best Under $20 Stocks to Buy in June 2024
Via InvestorPlace
Blue-Chip Jackpots: 3 Top-Notch Stocks at Bottom-Barrel Prices
Via InvestorPlace
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
From FN Media Group LLC
Via GlobeNewswire
Payout Powerhouses: 7 Dividend Stocks to Buy Now
Via InvestorPlace
Dividend Heaven: 7 Standout Stocks for Income Investors to Buy in June
Via InvestorPlace
Topics Retirement
Exposures Pension
Talc Plaintiffs File Motion for Temporary Restraining Order to Limit Johnson & Johnson’s Use of Bankruptcy Strategy
From Beasley Allen Law Firm
Via Business Wire
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
Johnson & Johnson To Pay $700M To Settle Multi-State Talc Investigation
Via Benzinga
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Stocks You Can Safely Hold for the Long Haul
Via The Motley Fool
7 Recession-Proof Stocks to Buy Now for Peace of Mind
Via InvestorPlace
The 3 Most Undervalued Robinhood Stocks to Buy in June 2024
Via InvestorPlace
Time to Pounce: 2 High-Yielding Dow Stocks That Are Begging to Be Bought Right Now
Via The Motley Fool
Topics Stocks
Exposures US Equities
The Safety Net Seven: 7 Stocks to Own for Unshakeable Returns
Via InvestorPlace
3 Stocks to Buy With 20% Upside
Via The Motley Fool
The 3 Best Dow Stocks to Buy in June 2024
Via InvestorPlace
Topics Stocks
Exposures US Equities
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.